A detailed history of Alexander Randolph Advisory, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Alexander Randolph Advisory, Inc. holds 6,965 shares of AMGN stock, worth $2.24 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
6,965
Previous 7,030 0.92%
Holding current value
$2.24 Million
Previous $2.2 Billion 2.17%
% of portfolio
1.99%
Previous 2.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$309.38 - $337.38 $20,109 - $21,929
-65 Reduced 0.92%
6,965 $2.24 Billion
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $38,098 - $46,299
-145 Reduced 2.02%
7,030 $2.2 Billion
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $11,561 - $13,956
-43 Reduced 0.6%
7,175 $2.04 Billion
Q4 2023

Feb 02, 2024

BUY
$255.7 - $288.46 $1.85 Million - $2.08 Million
7,218 New
7,218 $2.08 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alexander Randolph Advisory, Inc. Portfolio

Follow Alexander Randolph Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alexander Randolph Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alexander Randolph Advisory, Inc. with notifications on news.